China Drug Distribution: More "Two Invoice" Changes
415 Views27 Feb 2018 11:34
The restructuring of China's drug distribution industry continues with Baiyunshan Phrmcl Hldgs Co Ltd (874 HK)'s pending buyout of Walgreens Boots...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Kemp Dolliver, CFA
Founder
Price Chart(Sign Up to Access)
- Sinopharm (国医控股) Placement - Unattractive but Inexpensive16 Jan 2020
- China Medical Devices: "Two-Invoice" Is Coming21 Aug 2018
- China Drug Distribution: More "Two Invoice" Changes27 Feb 2018
- Walgreens Invests in Sinopharm Retail Arm03 Dec 2017
- Shanghai Pharma Gets Cardinal Health Deal17 Nov 2017
- Cardinal to Depart China: A Good Play for Distributors25 Jul 2017
x